Literature DB >> 17526627

The neurobiological and neurocognitive consequences of chronic cigarette smoking in alcohol use disorders.

Timothy C Durazzo1, Stefan Gazdzinski, Dieter J Meyerhoff.   

Abstract

A vast body of research attests to the adverse effects of chronic smoking on cardiac, pulmonary, and vascular function as well as the increased risk for various forms of cancer. However, comparatively little is known about the effects of chronic smoking on human brain function. Although smoking rates have decreased in the developed world, they remain high in individuals with alcohol use disorders. Despite the high prevalence of comorbid chronic smoking in alcohol use disorders, very few studies have addressed the potential neurobiological or neurocognitive effects of chronic smoking in alcohol use disorders. Here, we briefly review the existing literature on the neurobiological and neurocognitive consequences of chronic cigarette smoking and summarize our neuroimaging and neurocognitive studies on the effects of comorbid chronic excessive alcohol consumption and cigarette smoking in treatment-seeking and treatment-naïve populations. Our research suggests comorbid chronic cigarette smoking modulates magnetic resonance-detectable brain injury and neurocognition in alcohol use disorders and that neurobiological recovery in our abstinent alcoholics is adversely affected by chronic smoking. Consideration of the potential separate effects and interactions of chronic smoking and alcohol consumption may foster a better understanding of specific mechanisms and neurocognitive consequences of brain injury in alcoholism and of brain recovery during sustained abstinence from alcohol. The material presented also contributes to ongoing discussions about treatment strategies for comorbid alcoholism and cigarette smoking and will hopefully stimulate further research into the neurobiological and neurocognitive consequences of chronic smoking in alcoholism and other substance use disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17526627     DOI: 10.1093/alcalc/agm020

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  54 in total

1.  Alcohol-induced psychotic disorder: brain perfusion and psychopathology--before and after anti-psychotic treatment.

Authors:  Gerhard P Jordaan; James M Warwick; Daan G Nel; Richard Hewlett; Robin Emsley
Journal:  Metab Brain Dis       Date:  2011-12-07       Impact factor: 3.584

2.  Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine-Derived Nitrosamine Ketone-Associated White Matter Degeneration.

Authors:  Emine B Yalcin; Kavin Nunez; Ming Tong; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2015-12       Impact factor: 3.455

3.  Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.

Authors:  Daniel J O Roche; Spencer Bujarski; Emily Hartwell; ReJoyce Green; Lara A Ray
Journal:  Pharmacol Biochem Behav       Date:  2015-04-28       Impact factor: 3.533

4.  Executive functions and substance use: Relations in late adolescence and early adulthood.

Authors:  Daniel E Gustavson; Michael C Stallings; Robin P Corley; Akira Miyake; John K Hewitt; Naomi P Friedman
Journal:  J Abnorm Psychol       Date:  2017-01-02

5.  Mechanisms of postural control in alcoholic men and women: biomechanical analysis of musculoskeletal coordination during quiet standing.

Authors:  Edith V Sullivan; Jessica Rose; Adolf Pfefferbaum
Journal:  Alcohol Clin Exp Res       Date:  2009-12-17       Impact factor: 3.455

6.  The Association of Panic Disorder, Posttraumatic Stress Disorder, and Major Depression With Smoking in American Indians.

Authors:  Craig N Sawchuk; Peter Roy-Byrne; Carolyn Noonan; Andy Bogart; Jack Goldberg; Spero M Manson; Dedra Buchwald
Journal:  Nicotine Tob Res       Date:  2015-04-06       Impact factor: 4.244

7.  The effects of chronic cigarette smoking on cognitive recovery during early abstinence from alcohol.

Authors:  David L Pennington; Timothy C Durazzo; Thomas P Schmidt; Anderson Mon; Christoph Abé; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2013-02-21       Impact factor: 3.455

8.  Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence.

Authors:  Thomas P Schmidt; David L Pennington; Stephanie L Cardoos; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  J Clin Exp Neuropsychol       Date:  2016-10-03       Impact factor: 2.475

9.  Differences in White Matter Microstructure and Connectivity in Nontreatment-Seeking Individuals with Alcohol Use Disorder.

Authors:  Evgeny J Chumin; Joaquín Goñi; Meredith E Halcomb; Timothy C Durazzo; Mario Dzemidzic; Karmen K Yoder
Journal:  Alcohol Clin Exp Res       Date:  2018-04-14       Impact factor: 3.455

Review 10.  Tobacco smoking and MRI/MRS brain abnormalities compared to nonsmokers.

Authors:  E F Domino
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-09-11       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.